- Home
- A-Z Publications
- Coronaviruses
- Fast Track Listing
Coronaviruses - Online First
Description text for Online First listing goes here...
40 results
-
-
Plant-based Therapeutics for Aspergillus Co-infections in COVID-19 Patients Illuminating Phytochemical Mechanisms
Authors: Harjeet Singh, Shivani R. Pandya, Alpa Yadav, Parmdeep Singh Dhanda, Prashant Kaushik and Mukul JainAvailable online: 06 January 2025More LessThe emergence of COVID-19 has highlightedthe issue of secondary fungal infections, such as COVID-19-Associated invasive Pulmonary Aspergillosis (CAPA), in critically ill patients. Continuous use of therapies employing steroids and immune-modulating agents has increased the risk of co-infections resulting from fungi, further weakening the respiratory systems of patients and leading to complex situations such as multi-organ failure and elevated mortality. The increasing occurrence of antifungal resistance in Aspergillus strains has made the management of these infections challenging, highlighting the need for novel and effective antifungal agents. Plants and their bioactive compounds offer promising alternatives to conventional antifungal medications. Phytochemicals such as 1,8-cineole from Eucalyptus, thymol from commercial extracts, and cinnamaldehyde from cinnamon have demonstrated significant antifungal activities by targeting fungal cell walls, membranes, and gene expression. Additionally, compounds like eugenol from cloves and citral from lemongrass exhibit potent antimicrobial effects by disrupting cellular integrity. However, challenges such as variability in phytochemical content, limited clinical data, and potential drug interactions must be addressed. This review explores the potential of plant-based medicines for treating aspergillosis, emphasizing the need for further research to validate their effectiveness, safety, and optimal dosages through clinical studies.
-
-
-
Emerging Threat: A Review on Mucormycosis as a Serious Health Challenge During the Pandemic
Available online: 06 January 2025More LessDuring the COVID-19 pandemic, many critically ill patients undergoing intensive care or ventilation developed a fungal infection known as Mucormycosis. This infection is primarily caused by ubiquitous fungi in the environment, such as species like Rhizopus arrhizus, Lichtheimia, Mucor, and Rhizomucor, among others. Symptoms range from mild, such as fever and nasal congestion, to more severe manifestations, like gastrointestinal bleeding and dark lesions in moist body areas such as the nose and eyes. Mucormycosis can be fatal if not promptly treated with appropriate combination therapy, and in severe cases, surgical removal of infected tissue may be necessary. This review explores the historical background, epidemiology, and treatment strategies for Mucormycosis. It also discusses its prevalence among COVID-19 patients, underlying causes, and management protocols.
-
-
-
COVID 19: Variants, Diagnosis and Vaccines- An Update
Authors: Parul Chauhan, Ankita Tiwari, Okoro Emmanuel and M. Arockia BabuAvailable online: 30 December 2024More LessIn 2019, a life-threatening virus, SARS-Cov 2 emerged in China and caused destruction all around the world, affecting many lives; the origin of this virus is still debatable and unclear. The coronavirus is a contagious disease with high rates of transmission; it mutates rapidly and now has variants, some of which have caused a lot of damage to lives and the economy. These variants are mainly classified into three main groups: a) variants of concern; b) variants of interest; and c) variants under monitoring. Vaccines are the safest and most effective option for preventing covid and saving lives, as building immunity and breaking the chain of transmission is essential even though vaccines that have been developed till now have different effects against different variants of coronavirus. As it is known that vaccines are the main shield to protect from coronavirus, due to rapid mutation and slow developments of vaccines several people are still getting infected with covid-19. Many treatment options are available, such as antiviral drugs, nanotechnology, plasma therapy, and monoclonal antibodies. Besides prevention and treatment, correct diagnosis of the disease is essential, and for this purpose, different diagnostic techniques are discussed in this article alongside the possible future of COVID-19.
-
-
-
The Association Between COVID-19 Vaccination Among Pregnant Women and Neonatal Outcomes: A Systematic Review and Meta-Analysis
Available online: 30 December 2024More LessBackground and AimLimited data exist regarding the safety of COVID-19 vaccines during pregnancy. Despite some studies supporting vaccine safety and efficacy in pregnant women, hesitancy persists. Hence, this study aims to evaluate vaccination effects on pregnancy and neonatal outcomes in vaccinated pregnant women compared to unvaccinated controls.
MethodsWe conducted a comprehensive literature search in databases including PubMed, Web of Science, and Scopus without any time restrictions up to September 2023. We used specific Medical Subject Headings (MeSH) terms and keywords related to COVID-19, pregnancy, neonatal outcomes, and vaccination. Studies without control groups, lacking neonatal outcome data, or not in English were excluded. Data on preterm births, small for gestational age, NICU admissions, low APGAR scores, and low birth weights were extracted and analyzed using statistical methods to pool odds ratios and assess heterogeneity and publication bias.
ResultsFinally, 27 studies were included in our final analysis. Vaccinated mothers exhibited a lower prevalence of preterm birth, with a pooled OR of 0.78 (95% CI: 0.70, 0.87, p-value < 0.01). No significant difference was found in the prevalence of SGA between the two groups, with a pooled OR of 0.99 (95% CI: 0.92, 1.07, p-value = 0.77). There was no significant difference in NICU admissions between the two groups, with a pooled OR of 0.89 (95% CI: 0.60, 1.32, p-value = 0.57). Conversely, unvaccinated mothers had a significantly higher prevalence of low 5-minute APGAR scores, with a pooled OR of 0.84 (95% CI: 0.72, 0.98, p-value = 0.02), and low birth weight, with a pooled OR of 0.83 (95% CI: 0.70, 0.97, p-value = 0.02).
ConclusionOur results demonstrated a significant decrease in the odds ratio of preterm birth, low birth weight, and low APGAR scores among those who received COVID-19 vaccination. However, we did not find a significant link between COVID-19 vaccination and the risk of NICU admission or the SGA.
-
-
-
A Mini Review on Effect of Corona Virus on Cancer Related to Lungs
Authors: Ujjwal Chauhan, Nitesh Kumar, Arshdeep Chopra, Yash Sharma, Ajay Pal Singh, P.K Sharma and MahimaAvailable online: 30 December 2024More LessThe emergence of the COVID-19 pandemic, caused by the SARS-CoV-2 virus, has significantly impacted cancer patients, particularly those with lung cancer. This review delves into the intersection of COVID-19 and lung cancer, addressing concerns regarding diagnosis, treatment, and outcomes. Research demonstrates that patient co-factors, including age, sex, blood type, and knowledge levels, are strongly associated with the severity and mortality of COVID-19 in lung cancer patients. Older age, male gender, and specific blood types correlate with worse results. Cancer patients, already immunocompromised, face heightened risks from COVID-19, with increased morbidity and mortality rates. The pandemic has necessitated rapid adjustments in oncological care, including telemedicine and altered treatment protocols. Vaccination tactics are essential, with effectiveness differing based on whether patients have gotten the initial dosage, second dose, or booster doses. Various vaccination forms, including mRNA vaccines, viral vector vaccines, and inactivated virus vaccines, have differing effectiveness profiles, particularly in immunocompromised persons. Booster dosages have shown improved immunity against developing variations such as Delta and Omicron. Lung cancer, the second most diagnosed cancer globally, presents diverse challenges due to its association with smoking and exposure to environmental carcinogens. Diagnosis relies on histological confirmation, with treatment decisions guided by disease staging and molecular profiling. Innovative diagnostic tools, such as molecular markers and genetic sequencing, enhance personalized treatment approaches. The pandemic's impact on cancer diagnosis and treatment pathways underscores the need for vigilant surveillance and adaptive strategies to ensure optimal patient care. This abstract encapsulates the critical considerations and evolving landscape of managing COVID-19 and lung cancer, emphasizing the importance of tailored approaches in navigating these intertwined health crises. The abstract summarizes the diagnostic and management approaches for lung cancer and COVID-19, highlighting key methods such as radiographic screening, liquid biopsy, sputum examination, and nucleic acid amplification tests for diagnosis. Treatment strategies for both conditions are discussed, emphasizing the challenges faced by lung cancer patients, particularly in the context of COVID-19 infections. The abstract also addresses the importance of early detection through biomarker discovery and the development of new therapies tailored to individual patients. Furthermore, prognostic and predictive biomarkers for lung cancer are identified, such as EGFR mutations and ALK rearrangements, which inform treatment decisions. The abstract underscores the need for comprehensive care strategies that consider the intersection of lung cancer and COVID-19, ensuring optimal outcomes for affected patients. Ultimately, care strategies must take consideration of patient co-factors like age, sex, blood group, and knowledge levels, as well as vaccine administration schedules like first doses, second doses, and booster shots and vaccine type reflections. The overall strategy aims to improve treatment and immunization efficacy, improving lung cancer outcomes during the COVID-19 pandemic.
-
-
-
Neurofunctional Impacts of COVID-19: Memory Loss and Cognitive Decline and Treatment
Available online: 27 December 2024More LessAlthough SARS-CoV-2, the virus that causes COVID-19 has been responsible for pneumonia, recent studies indicate that it also affects the kidneys, heart, and brain, among other vital organs. Evidence suggests that this virus may travel retrogradely from the olfactory epithelium to brain stem sections, causing neurological impairments in a significant number of individuals. Individuals with severe COVID-19 frequently have elevated cytokines that promote inflammation and acute respiratory failure and require frequent supportive ventilation. These factors are believed to contribute to cognitive deterioration. Severe neurological outcomes in COVID-19 patients include- paralysis, stroke, cranial nerve deficits, delirium, encephalopathy, seizures, and meningitis. The virus, with its unique structure, and a high binding affinity for the human enzyme ACE2 (used as an entry point by the virus), contributes significantly to its deadly nature. Furthermore, to address the outbreak effectively, researchers worldwide must develop precise treatment strategies. Advancing new diagnostic and treatment methods to mitigate the long-term effects of COVID-19 on cognition requires further epidemiological research and clinical experience. Additionally, by understanding the virus's impact on cognitive functions, healthcare professionals can develop targeted treatments to alleviate these severe neurological consequences.
-
-
-
Knowledge, Attitude, and Practice of Novel Coronavirus (COVID-19) Among Young Adults in Iraq
Available online: 27 December 2024More LessBackgroundSociety's information regarding practices, attitudes, and knowledge influences the society's behaviors and practices toward COVID-19 and affects preventive measures and disease control.
AimThis study aims to assess the knowledge, attitude, and practices towards COVID-19 in the young adults of the Iraqi general population.
Materials and MethodsCross-sectional study web-based survey conducted between 30th September 2023 to 31st January 2024. The data was gathered through an electronic questionnaire. The survey was conducted in the Iraqi population and included male and female participants aged ≥ 18 years. A self-administered structured questionnaire was used for data gathering. The questionnaire consists of items to get information from the participants: risk factors, knowledge, attitudes and practices toward SARS-CoV-2 infection, and social and demographic characteristics. An Arabic version of the questionnaire was prepared. The questionnaire consists of the knowledge part, which includes 11 questions, while attitudes include 10 questions and practices include 8 questions. The knowledge was evaluated on the basis of the correct answer and converted to a score of 5. While for the attitudes, a 5-point Likert-type scoring system was created for responses (1- strongly disagree; 2- disagree; 3-neutral; 4- agree; 5- strongly agree). For the practices, a 5-point Likert score is used for response evaluation (5- always; 4- often; 3- sometimes; 2- rarely; 1-never). The questionnaire link was sent online to the participants via Facebook, Instagram, Telegram, and WhatsApp. The questionnaire participants replied in the Microsoft Excel sheet. An ANOVA test was used to determine the differences in significance between the KAP items and within the section of each KAP. Post-hoc test used for analysis of significance between K and A, K and P, A and P. The significance of the differences between groups was determined using the chi-square test. The analysis was performed using SPSS version 20.
ResultsThere were 1484 participants, with a survey response rate of 86.7% (1484/1712). The majority of the participants (69.3%) were in the age group of 18 to 25 years, and 85.9% of them were B.Sc., M.Sc., Ph.D., and college students. 90.5% were from urban areas, and 27.6% participated in an online course for COVID-19. The mean score of knowledge was 3.04 ± 0.84, which means that the mean correct answer of the knowledge item was 61%. The highest correctly answered question (87%) was regarding the preventive measures for COVID-19 infection, followed by the main symptoms of COVID-19 (76.5%). The lowest correctly answered question (27%) was regarding the mortality rate of COVID-19, followed by complications of COVID-19 (38.1%). The total knowledge mean score was 61% of the scale (score 3.04/5), and this indicated that 61% of the population has good knowledge regarding the COVID-19 pandemic. Additionally, there were high significance (p < 0.01) differences between the knowledge item score and the correct answer. A post-hoc test indicated a significant difference (p = 0.0305) in item scores between knowledge and practices, but there was no significant difference between knowledge versus attitudes or between attitudes versus practices. Attitudes mean score was 3.6 and 72% frequency of correct answers for the items. A significant number of participants expressed worry about themselves, their family members, friends, or society (64.8%) getting infected. Thus, about 1/3 of the participants were not worried about getting an infection. However, 18.4% of participants did not express any as they gave a neutral answer. It is interesting that 80.3% of the participants believed that an asymptomatic patient could transmit the virus to others. The survey indicated a rate with an average of 12.5% to 36% of neutral responses to the addressed questions. The mean score of practice was 9.98 and the correct answer frequency was 79.6%. The majority of participants (83.3%) reported an acceptable practice. Individual questions were answered correctly in a range of 88.1% to 94.7%, with the exception of carefully removing PPE and discarding it in the proper place (17.1%).
ConclusionsThe young adults Iraqi general population had a good KAP standard. Attitudes and practice scores were higher than those of knowledge. The knowledge score mean value was 3.04 and the correct answers frequency was 61%, with the items score range of 1.4 and 4.4, while the correct answers frequency range was 27% and 87%. The mean score of attitudes was 3.6 with a range of 2.8–4.2, while the correct mean frequency was 72% with a range of 56% to 84%. The mean score of practices was 3.98 with a range of 1.6 to 4.5, while the mean frequency of the correct answer was 79.6% with a range of 32% to 90%.
-
-
-
Investigating the Level of Knowledge of Nurses Working in Educational Hospitals of Ilam about COVID-19 in Iran
Authors: Masoumeh Shohani, Mohamadreza Kafashian and Hamed TavanAvailable online: 23 December 2024More LessIntroductionSince nurses are responsible for caring of patients, increasing their knowledge will lead to better care. Here, we measured nurses’ COVID-19 knowledge in the teaching hospitals of Ilam.
Materials and MethodsIn this study, descriptive-analytical approach was used for data collection using a self-assessment questionnaire including demographic information and 12 questions about nurses' knowledge of COVID-19 disease. The data were collected in May 2020 and analyzed by SPSS 19 software. The significance level was considered at P <0.05.
ResultsOverall, 134 (72.4%) and 51 (27.6%) of the participants were males and females, respectively. The mean score of knowledge about COVID-19 disease was 6.04± 0.45. Nearly half of the nurses (45.4%) had good knowledge on the source of the disease, signs and symptoms, transmission routes, and progression and mortality rate of COVID-19.
ConclusionMost of the nurses had intermediate knowledge about COVID-19. However, it is essential for the Ministry of Health to provide accurate and coherent information according to the WHO guidelines.
-
-
-
Outbreak Transmission of Coronavirus- A Case Study
Available online: 23 December 2024More LessIntroductionThe COVID-19 pandemic, originating in Wuhan, China, swiftly spread globally, wreaking havoc on both personal lives and economic stability.
MethodIts highly contagious nature, transmitted through human contact, necessitated urgent government interventions worldwide. Measures such as quarantine, social distancing, and lockdowns, alongside medical awareness campaigns, were earnestly adopted to mitigate its impact.
ResultsWhile the development of a cure remains a time- consuming endeavor, the focus has shifted towards prevention through diverse strategies, explored in this study.
ConclusionPresenting a stochastic model, this paper aims to analyze the percentage of affected individuals across various factors, highlighting the efficacy of lockdown measures at different intervals.
-
-
-
SARS CoV-2 Delta Variant Spike Protein: Structure, Mechanism, and Docking Interaction with Antiviral Ligands from the Plants of the Phyllanthus Genus
Available online: 16 December 2024More LessAn abrupt outbreak of “Severe Acute Respiratory Syndrome Coronavirus 2” was first identified in Wuhan City, Hubei Province, China, in December 2019, which was later disseminated globally. Individuals afflicted with this highly transmissible virus contribute to a significant public health crisis. The lack of specific vaccinations and antiviral medications for nCoV-2019, together with the emergence of mutations in the genome of the virus, necessitates a multifaceted approach to drug design and discovery for COVID-19. A comprehensive worldwide supervision plan is essential for the accurate forecast and prevention of viral infections. The SARS-CoV-2 spike (S) protein plays a crucial role in viral binding, fusion, and entrance, hence influencing the generation and evolution of antibodies and vaccines. The receptor binding domain (RBD) of the SARS-CoV-2 spike protein exhibits a significant affinity for human angiotensin-converting enzyme 2 (ACE2) receptors. It encompasses diverse mutations in the N-terminal domain (NTD) and the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein, enhancing immunological efficacy. The B.1.617.2 mutant, also known as the Delta variation, is expected to spread more rapidly than earlier versions. Thus, in this study, we have evaluated the structural characteristics of the SARS-CoV-2 spike protein and the human ACE2 protein and their interactions and examined putative SPIKE-ACE2 protein-protein inhibitors derived from the phytocompounds of Phyllanthus species. This is the crucial aspect for the advancement of economical clinical trials of individual plant components for the treatment of viral diseases.
-
-
-
The Impact of Diabetes-related Factors on the Severity and Outcome of COVID-19 Infection in Hospitalized Patients: A Descriptive-analytical Study
Available online: 16 December 2024More LessIntroductionThe COVID-19 pandemic is having a devastating impact on public health, with a higher risk of severe illness and mortality in vulnerable groups. Individuals with a history of diabetes are more prone to severe COVID-19. A collection of hyperglycemia, inflammation, and impaired immunity in diabetes, especially in poor glycemic control, notably increases the risk of COVID-19 severity. Hyperglycemia can trigger the release of inflammatory cytokines, highlighting the intricate relationship between glucose metabolism and inflammation, and contributing to cytokine storms that worsen COVID-19 severity. Understanding this relationship enables healthcare providers to develop personalized care strategies for managing blood glucose in diabetic patients, thereby reducing the risk of severe COVID-19 outcomes. This study aims to identify the factors that contribute to the severe outcomes of COVID-19 in patients with diabetes, to better understand and manage this critical combination.
MethodsA total of 411 patients with COVID-19 infection referred to the Teaching Hospital of Mazandaran University of Medical Sciences, Sari, were included in this study. The COVID-19 severity was evaluated according to the World Health Organization (WHO) guidelines. All information including demographic, clinical, and laboratory data as well as severity and outcome of the disease were compared between diabetic and non-diabetic patients.
ResultsThe diabetic patients had higher blood glucose (210.3 ±114.9 mg/dl) compared to non-diabetics (118.74 ±3.8 mg/dl) upon admission (p=0.0001). Diabetics also experienced more severe COVID-19 infection (p=0.048). Patients with severe COVID-19 had significantly higher blood glucose (168.5 ±12.8 mg/dl) than those with non-severe infection (136.6± 6.3 mg/dl) (p=0.013). Diabetics had higher erythrocyte sedimentation rates (ESR) compared to non-diabetics (52.25±2.4 vs. 43.81±1.8 mm/h, p=0.006). Diabetic patients taking ACEIs/ARBs had more severe COVID-19 infection (p=0.031).
ConclusionThe study discovered a positive relationship between hyperglycemia and COVID-19 severity, as well as a higher risk of severe COVID-19 among patients taking ACEIs or ARBs.
-
-
-
The XEC COVID-19 Variant: A Global Threat Demanding Immediate Action
Authors: Afzal Hussain, Ashfaq Hussain, Walid A. H. Eldaif and Mohammad RashidAvailable online: 16 December 2024More LessThe new XEC variant that has recently been described, a recombinant strain originated from the Omicron sub-lineages KS1.1 and KP3.3 (also known as FLuQE; it is descended from the FLiRT lineage), has since early July, 2024, been confirmed in more than 15 EU countries as well as North America and Asia. Currently, the XEC variant is reported in 27 countries, including America, Britain, and China, with T22N and Q493E in the spike that gives it a transmission advantage, meaning that it may be the dominant strain in this coming winter season. Like past COVID-19 strains, XEC has caused flu-like signs, including fever, sore throat, and body aches. Thus, the high efficacy of vaccines in preventing severe disease and hospitalization cannot negate the necessity to pay attention to XEC, increase public health measures, and improve genomic surveillance due to the high transmissibility of the virus and slight advantage in transmission. This letter urges people worldwide to pay attention to how XEC is spreading and to act quickly to stop new cases from rising, especially among the susceptible groups.
-
-
-
The Severity of Disease and Hospital Length of Stay for the First and Second Admission of COVID-19 Patients: An Observational Study from Southeastern Iran
Available online: 13 December 2024More LessBackgroundThis study aimed to investigate the severity of disease and length of hospital stay for COVID-19 patients admitted to a hospital in southeastern Iran.
MethodThis cross-sectional study was conducted in Kerman, Iran. Data were collected from patients who visited Afzalipour Hospital in Kerman more than twice during the COVID-19 epidemic from the end of February 2020 to March 21, 2021. We conducted two key analyses: 1. Mixed effect logistic regression was used to check the relationship between the variables and COVID-19 severity. 2. Mixed effect linear regression was used to check the relationship between the variables and the length of stay in the hospital.
ResultsThe findings indicated that the most important risk factors for the severity of COVID-19 were heart diseases (OR=1.67,95%CI:1.20-2.30), increasing age (OR=2.23 for age>54, 95%CI:1.70-2.90), male gender (OR=1.47,95%CI:1.10-1.96), respiratory diseases other than asthma, and frequency of admission (OR=1.60,95%CI:1.20-2.15). All patients who underwent readmission experienced a shorter duration of hospitalization during their subsequent admission (OR=0.94,95%CI:0.91,0.96) and had a higher mortality rate (30% within 14 days, 26.6% between 14-90 days). Patients readmitted at intervals of 14-90 days and greater than 90 days exhibited lower disease severity compared to those readmitted within the 0-14 day period.
ConclusionExamining readmissions, the severity of COVID-19, and the length of hospital stay in affected patients are important factors for planning and allocating resources for COVID-19 management and treatment. These factors can help policymakers develop effective clinical guidelines for hospitalization or outpatient treatment of COVID-19 patients and contribute to reducing the burden of disease in the community.
-
-
-
The Impact of the Coronavirus Pandemic on Telemedicine Evolution in Obstetrical Care During COVID-19
Authors: Dr Wassan Nori, Amenah Fadhil and Zainab Abdul Ameer JaafarAvailable online: 13 December 2024More LessThe COVID-19 pandemic has imposed drastic challenges to the health system and resulted in drastic measures to reduce the high morbidity and mortality rates observed among affected individuals. Pregnant women were faced with an unexpected suspension of anti-natal care with the recommendation of indoor confinement. Telemedicine (Tm), defined as the delivery of healthcare via communication, stood up as a valuable tool to address those needs with its convenience of remote monitoring and ease of use. This review aimed to verify the transition of Tm in obstetrical care, define factors and barriers associated with its acceptance, its performance, and how it evolved during the COVID-19 era to guide its role in modern obstetrics. Four electronic repositories were searched: PubMed, Scopus, WOS, and Google Scholar using the keywords (pregnant, telemedicine, COVID-19, feto-maternal health, outcome, satisfaction, and health care); eligible studies were included in the analysis. Despite the challenges and difficulties faced by Tm during its early implementation in the pandemic, its effectiveness was demonstrated. Looking back to the lessons learned from the pandemic, Tm stood out as a reliable, safe, cost-effective tool for delivering anti-natal care during lockdown. Its role in alleviating anxiety and stress associated with the pandemic was notable. There are still gaps in our knowledge that need to be researched further, practically, the long-term outcome of Tm follow-up for both the mothers and their babies, and from a lower income countries' perspective as Tm services faced digital literacy in those areas. It has been anticipated that Tm will play a crucial role in modern obstetrics, as an integral part of the health service or as a complete part. Moreover, by adopting the 2 models, pregnant women will have the leverage of to aim for better delivery and outcomes in the presented health care.
-
-
-
Investigating the Relationship Between Postpartum Depression, Antenatal Depression, Corona Disease Anxiety, and Personality Traits During the COVID-19 Pandemic
Available online: 03 December 2024More LessBackground and AimPostpartum depression has a profound impact, both physically and psychologically, on both the mother and her newborn. With a focus on the prevalent psychological complications following the onset of this condition, this study aimed to explore the correlation between antenatal depression and Corona disease anxiety, personality traits, and postpartum depression during the COVID-19 pandemic.
Materials and MethodsThis cross-sectional descriptive-analytical study investigated women receiving care at health centers affiliated with Kerman University of Medical Sciences during the last month of their pregnancy and the postpartum period in 2022. Following the acquisition of informed consent, participants were assessed using various measures, including demographic and obstetric information, the Edinburgh Postnatal Depression Scale, the Corona Disease Anxiety Scale (CDAS), and the NEO Personality Inventory-Revised during their third trimester of pregnancy. The same group of participants completed the Edinburgh Depression Scale and the Corona Disease Anxiety Scale (CDAS) 4-6 weeks after childbirth.
ResultsThere was a significant correlation between family income, unwanted pregnancy as perceived by both the mother and father, and antenatal depression. Additionally, marital satisfaction played a significant role in postpartum depression. Furthermore, antenatal depression was significantly associated with neuroticism, agreeableness, and physical symptoms related to Corona disease anxiety. Personality traits, with the exception of extroversion and conscientiousness, and various domains of Corona disease anxiety, excluding psychological symptoms, were also significantly associated with postpartum depression.
ConclusionDuring pandemics or epidemics, such as the COVID-19 outbreak, experiencing mental distress during pregnancy can contribute to mental health issues during the postpartum period. This risk is particularly true in individuals with unique personality traits, emphasizing the need for increased focus on mental health within prenatal care during these crises.
-
-
-
Investigating the Relationship Between the Levels of Hematological and Biochemical Parameters of COVID-19 Patients with the Length of Hospitalization
Available online: 03 December 2024More LessBackgroundIdentifying and treating patients with COVID-19 requires the use of quick and precise laboratory diagnostic techniques that assess the patient's health and identify the illness..
AimThis study was conducted to determine the relationship between hematological and biochemical parameters and length of hospitalization in patients with COVID-19.
MethodsThis is a cross-sectional study of a descriptive-analytical type, which was conducted by census method on 360 medical records of patients with COVID-19 in Imam Khomeini Hospital in Jiroft in 2022. Data were analyzed using descriptive and inferential statistics tests.
ResultsThe average number of days of hospitalization in the present study was 4 days. The rate of COVID-19 was higher in men than in women. The most common underlying diseases in the patients were heart, pulmonary, and diabetes. Among the biochemical parameters, only lactate dehydrogenase (LDH), blood urea nitrogen (BUN), aspartate aminotransferase (AST), alanine transaminase (ALT), platelet (PLT), and erythrocyte sedimentation rate (ESR) parameters had a statistically significant relationship with the total length of hospitalization (P-value<0.001). LDH, AST, ALT, creatinine (Cr), creatine phosphokinase (CPK), blood sugar (BS), total bilirubin, and direct bilirubin parameters were higher than normal in hospitalized patients.
ConclusionThe results showed that there is a relationship between LDH, BUN, AST, ALT, PLT, and ESR parameters and the length of hospitalization of patients. The levels of LDH, AST, ALT, Cr, CPK, BS, total bilirubin, and direct bilirubin parameters in patients were higher than normal.
-
-
-
Combating Cholera in Syria: A Comprehensive Approach to Clean Water, Sanitation, and Vaccination
Authors: Komal, Priya Jindal, Sachin Joshi, Lovekesh Singh and Amandeep SinghAvailable online: 03 December 2024More LessIntroductionThis study presents a comprehensive strategy for combating cholera in Syria, with a focus on clean water initiatives, treatment, surveillance, and vaccination, and the critical role of clean water in halting disease transmission.
MethodsThe review design has involved a thorough research and review of existing literature and data on cholera outbreaks in Syria. It has also included an analysis of vaccination and treatment options, as well as an exploration of cholera surveillance systems and clean water initiatives.
ResultsKey findings have indicated that prioritizing access to clean water through community water management plans and water purification technologies is essential for cholera prevention. Case studies, supported by epidemiological data up to September 2023, have underscored the importance of clean water in stopping cholera spread.
ConclusionThe study has highlighted the urgent need for a comprehensive strategy to protect millions in Syria through enhanced water, sanitation, and vaccination measures. It has advocated for improved cholera surveillance and response systems, along with continued efforts to ensure clean water access for all.
-
-
-
Technology-based Solutions in Pandemic Era: A Deep Dive into COVID-19 Management with ChatGPT
Authors: Esmaeil Mehraeen, Niloofar Attarian, Amir Tabari and SeyedAhmad SeyedAlinaghiAvailable online: 08 November 2024More Less
-
-
-
Effects of COVID-19 on Food Supply: A Systematic Review
Available online: 01 November 2024More LessThe COVID-19 outbreak has had a significant influence on several critical industries, including agriculture, education, and the economy. This essay investigates these processes, with a focus on agriculture, where the repercussions have been particularly harsh for poor groups dealing with unpredictable food supplies and food safety.
Along with a critical examination of the shift to digital education systems, the report highlights the major obstacles that lie ahead for regions lacking adequate digital infrastructure and digital literacy. There have been notable disruptions in the economy as well. Manufacturing, the financial markets, and tourism have all seen major downturns.
The study emphasizes the crucial part that following safety measures and boosting immunization campaigns play in mitigating these negative consequences while supporting economic recovery. Also, new technical solutions have emerged throughout this time. The application of drone technology to contactless food delivery is a notable illustration of how creativity can overcome the challenges posed by the pandemic.
Finally, the report recommends the development of specific and rigorous methods to strengthen recovery efforts in these critical areas.
-
-
-
Revealing the Unseen: Post COVID-19 Biomarkers, Severity, and Outcome Mysteries
Available online: 30 October 2024More LessBackgroundAlthough the COVID-19 pandemic has passed, some patients still experience post-COVID-19 symptoms. It has been reported that COVID-19 symptoms can persist for more than three months after recovery.
ObjectiveThis study aims to analyze biomarkers, severity, and outcome factors associated with post-COVID-19 symptoms.
MethodsThis prospective cohort study involves hospitalised COVID-19 patients who were followed for up to 3 months after discharge. Clinical examinations and laboratory tests for MMP-9, TIMP-1, and IL-6 were conducted during hospitalisation and after three months.
ResultsWe enrolled 76 COVID-19 patients, with a mortality rate of 30.26%. Among them, 55 individuals (30.91%) had no residual symptoms, 54.5% had acute COVID-19, 9.09% had ongoing COVID-19, and 5.45% had long-term COVID-19. Symptomatic post-COVID-19 had oxygen demand and respiratory rates higher than no-symptoms groups. Early IL-6, IL-10, MMP-9, and TIMP-1 were lower in symptomatic post-COVID-19 compared to dead and asymptomatic post-COVID-19 groups. IL-6 and MMP-9 decrease, and TIMP-1 increases after cure. IL-6 significantly still increases in post-COVID-19 symptoms compared to no-symptoms (p=0.01). Patients more than 50 years old and critically ventilated patients are prone to have symptoms post-COVID-19.
ConclusionsMore than half of patients suffer from post-COVID-19 symptoms with various related factors. Even though IL-6 decreases after recovery, IL-6 levels are still higher in symptomatic post-COVID-19 patients.
-
-
-
Assessing the Efficacy and Challenges of Tofacitinib in the Management of COVID-19: A Systematic Review and Meta-analysis of Cohort Studies
Authors: Tahereh Dara, Mohsen Zabihi, Farahnaz Hoseinzade, Mohammad Reza Radandish, Fatemeh and SaghafiAvailable online: 29 October 2024More LessObjectivesGlobal healthcare faces challenges in combating COVID-19, with rising cases despite widespread vaccination. Severe COVID-19 cases, marked by acute respiratory distress and cytokine release syndrome, highlight the importance of managing cytokine storms. Janus kinase (JAK) inhibitors, such as tofacitinib, show promise in this regard. While tofacitinib is recommended for severe cases, challenges include adverse effects, conflicting studies, and the need for further investigation of new virus strains. Overcoming these hurdles is crucial for developing an effective treatment protocol and reducing COVID-19 mortality.
MethodsThis study conducted a comprehensive search across PubMed, Scopus, and ISI Web of Science for observational studies on tofacitinib treatment in human adults with COVID-19. The search covered a specified period up to 2024. Data extraction, including study characteristics and quality assessment, employed the Newcastle Ottawa Scale and a modified Cochrane tool. Statistical analysis, conducted with Comprehensive Meta-Analysis Software, assessed heterogeneity and significance levels.
ResultsThe meta-analysis of the three studies showed a significant reduction in mortality (Risk Ratio: 0.372, 95% CI: 0.213–0.649, P-value = 0.001) with low heterogeneity (Cochrane P-value = 0.793), while no significant reduction in the need for mechanical ventilation was observed (Cochrane P-value = 0.194).
ConclusionTofacitinib administration shows a significant reduction in COVID-19 mortality. However, the limited studies on its efficacy highlight the need for cautious interpretation in clinical assessments.
-
-
-
Evaluation of the Effect of Vaccination Status on Lung Involvement and Hospitalization in COVID-19 Patients
Authors: Ali Akin, Yılmaz Safi, Nilay Elif Bektaş and Hüseyin Avni DemirAvailable online: 22 October 2024More LessBackgroundThe spectrum of COVID-19 in adults ranges from asymptomatic infection to mild respiratory tract symptoms to severe pneumonia with acute respiratory distress syndrome (ARDS) and multiorgan dysfunction. In our study, it was aimed to investigate the effects of COVID-19 vaccine on lung involvement and hospitalization.
Materials and MethodsCases over the age of 18, who had a history of contact with cases infected with COVID-19 or had clinical findings suggestive of COVID-19, who applied to the emergency department and who were diagnosed with COVID-19 by reverse-transcriptase-polymerase chain reaction (RT-PCR) were included in the study. Age, gender, comorbid diseases, hospitalization status, thorax tomography findings, and vaccination status in the last 3 months of the patients included in the study were obtained by examining the hospital information system and patient files.
ResultsOur study included 496 patients. One hundred eighty-three of the cases were vaccinated and 42.6% (n = 78) of the vaccinated patients were male. Of the 313 unvaccinated patients, 36% (n = 113) were male. Comorbid disease was observed in 55.2% (n = 101) of the vaccinated patients and 38.7% (n = 121) of the unvaccinated patients. Of the 313 unvaccinated patients, 72.2% (n = 226) were discharged from the emergency department, 19.8% (n = 62) were admitted to the service, and 8% (n = 25) were admitted to the intensive care unit. Of the 183 vaccinated patients, 78.1% (n = 143) were discharged from the emergency department, 16.4% (n = 30) were admitted to the service, and 5.5% (n = 10) were admitted to the intensive care unit. In the vaccinated patient group, both the service admission rate and the intensive care hospitalization rate were found to be significantly lower than the non-vaccinated patient group (p < 0.05). Thoracic tomography findings of 32.9% (n = 103) of 313 unvaccinated patients were reported as CORADS 1-2-3, and thoracic tomography of the remaining 210 patients was reported as CORADS 4-5. The number of patients whose thorax tomography report was CORADS 4-5 was found to be significantly higher in the unvaccinated group than in the vaccinated group (p < 0.05).
ConclusionIn our study, it was found that vaccination significantly reduced hospitalization in COVID-19 patients. Although the mean age was higher in the vaccinated patient group, both the service admission rate and the intensive care admission rate were found to be lower.
-
-
-
Antibodies as Promising Molecules to Block Spike Glycoprotein from SARS-CoV2
Available online: 22 October 2024More LessCOVID-19 is caused by a new SARS-CoV-2 virus from the Coronaviridae family, responsible for developing severe acute respiratory syndrome (SARS-CoV). Its emergence in 2019 presented several challenges to global health. The virus can infect host cells using the ACE2 receptor, and after infection, several clinical manifestations appear, ranging from mild symptoms to death. One approach that has shown promising results is convalescent plasma since convalescent plasma (CP) consists of a concentrate of immunoglobulins in the blood of patients recently infected with the coronavirus for those currently infected. Therefore, this therapy uses antibodies in the plasma to neutralize the virus. This literature review aims to evaluate the efficacy of CP therapy in symptomatic COVID-19 patients by analyzing clinical trials and studies published between 2020 and 2023. Therefore, the search identified studies in which the majority reported the efficacy of using convalescent plasma to treat and alleviate the clinical condition of patients diagnosed with COVID-19. Important factors influence the efficacy of CP therapy, such as the timing of administration and the severity of the disease. Early administration in mild and moderate cases has shown promise. Furthermore, molecular docking analysis suggests that antibodies can cause conformational changes in the SARS-CoV-2 spike protein, raising the hypothesis that using CP may interfere with viral entry into host cells.
-
-
-
Unraveling the Effects of SARS-CoV-2 on Dementia: A Comprehensive Study
Authors: Sunil Kumar Kadiri and Prashant TiwariAvailable online: 21 October 2024More LessSince late 2019, a pandemic caused by SARS-CoV-2, a highly contagious coronavirus, has jeopardized human and public health. Neurodegeneration and structural brain diseases produce dementia, which is developing rapidly. Strong evidence of COVID-19 brain abnormalities as neurotrophic viruses impair neurological systems. Neuron and glial cell degeneration can affect nerve transmission and brain function. Damage to these brain components raises dementia risk. Multiple studies linked SARS-CoV-2 to dementia. This manuscript contains selective data. This study aims to review the findings and suggest strategies to improve SARS-Covid dementia management. The study makes use of medical research databases like Google Scholar, PubMed, Medline, and Embase. Furthermore, information is also collected by recognized health organizations and government agencies. COVID-19 can produce neuropsychological deficits, agitation, confusion, inattention, and disorientation. Thus, SARS can worsen dementia and neurodegeneration. This article summarizes COVID-19's effects on dementia patients from several sources. The focus on existing treatments for affected patients ties the two.
-
-
-
Mucormycosis: Current Perspectives on Treatment, Diagnosis, and Advancements
Authors: Tanya Biswas, Vikram Sharma and Ravi K. MittalAvailable online: 21 October 2024More LessObjectiveThis review study examines mucormycosis treatment challenges, gaps in medicines, and COVID-19-related effects. This paper examines diagnostic and drug development advances while addressing safety and specificity.
MethodsThis review study searches PubMed, Web Science, and Scopus for relevant material. Keywords associated with mucormycosis, therapy, diagnosis, medication advancement, and COVID-19 are used to identify pertinent articles. Data extraction summarizes therapeutic obstacles, diagnostic advances, and innovative drug options.
ResultsThis review article covers mucormycosis therapy, diagnostics, and drug development. It reveals limitations in present medicines, such as selectivity, safety, and resistance mechanisms. Diagnostic advances and mucormycosis in COVID-19 have also been explored.
ConclusionThis review emphasizes the need for more secure, specific mucormycosis therapies. It discusses therapy obstacles, diagnostic advances, and new drug techniques. Overall, this research emphasizes improving mucormycosis therapy to enhance patient outcomes.
-
-
-
Revisiting the COVID-19 Pandemic: A Comparative Analysis between Traditional and Synthetic Modes of Treatment with the Aid of In-silico Methods
Authors: Priyam Jyoti Das, Durgaprasad Kemisetti, Shiny Ahmed and Faruk AlamAvailable online: 16 October 2024More LessIntroduction/BackgroundThe COVID-19 pandemic has severely disrupted global health systems, highlighting the urgent need for effective treatment strategies. This article aims to provide an assessment of the pandemic's current status and examines the effectiveness of traditional treatments against innovative synthetic approaches.
Materials and MethodsThe article explores synthetic strategies involving repurposed antiviral drugs, supportive care, and vaccinations. It emphasizes the role of computational modeling and artificial intelligence in engineering molecules with potent antiviral properties. In-silico methods were utilized to accelerate chemical library screenings, predict efficacy, and assess interactions between viral proteins and potential treatments.
ResultsStudies employing molecular docking analysis have evaluated the efficacy of approved antiviral drugs and natural compounds. Notably, Azithromycin was found to have a potential inhibitory effect with a binding energy of -9.69, while natural compounds like Camphor and Curcumin displayed binding energies of -5.18 and -6.16, respectively.
DiscussionSynthetic treatments showed effectiveness in inhibiting viral proteins and facilitating rapid development, while natural products were more effective in preventing virus entry.
ConclusionBased on in-silico docking studies, it can be concluded that natural products have more therapeutic effects than synthetic drugs.
-
-
-
Thrombocytopenia and Other Hematological Features in COVID-19 Patients Referred to Shahid Mostafa Khomeini Hospital
Authors: Hassan Nourmohammadi, Elham Shafiei, Sanaz Mami and Hamed TavanAvailable online: 16 October 2024More LessIntroductionCOVID-19 is a deadly virus, but there is still no appropriate cure for it. Hence, the target of this study was to estimate the clinical value of thrombocytopenia and other blood parameters in COVID-19 patients referred to Ilam Shahid Mostafa Khomeini Hospital from April and September 2020.
Materials and MethodsIn this cross-sectional study, patients with thrombocytopenia, associated with COVID-19, diagnosed at the Shahid Mostafa Khomeini Hospital in Ilam City during the spring and summer of 2020 were included. A checklist was used to record the hematological indicators of the patients. Further, an analysis of data using SPSS V20 software was performed.
ResultsOverall, 66 thrombocytopenic patients were studied. Among patients who succumbed to the disease complications, 40 (67.8%) were male, and 19 (32.2%) were female. Mortality and survival rates were 90% and 10%, respectively.
ConclusionDue to the high mortality rate of COVID-19 patients with thrombocytopenia, platelet count can be considered a major risk factor, as well as a prognostic and diagnostic indicator in these patients.
-
-
-
Evaluation of Mental Health Status of Obstetrics and Gynecology Assistants during the COVID-19 Pandemic in Iran - A Cross-sectional Study
Available online: 15 October 2024More LessBackgroundSome evidence shows that the COVID-19 pandemic has had negative effects on the mental health status of different sections of society, including the medical staff.
AimsThe current study was conducted with the aim of investigating the mental health status of obstetrics and gynecology (OB-GYN) assistants during the COVID-19 pandemic in Iran.
MethodsThe present cross-sectional study was conducted in 23 hospitals across Iran in 2021 (January-March). Four hundred OB-GYN assistants were randomly and voluntarily enrolled in the study. The instrument used in this study was the 28-item General Health Questionnaire (GHQ-28), which had four subscales, including somatic symptoms, anxiety/ insomnia, social dysfunction and severe depression. To collect data and to reach respondents in distant areas, the questionnaires were provided to the OB-GYN assistants by the online platform.
ResultsThe mean age of the OB-GYN assistants was 32.3±2.6 years, and all were female. Of 400 OB-GYN assistants, 132 (33%) had no distress and 268 (67%) had psychiatric distress. According to subscales scoring, 72 (18%), 68 (17%), 92 (23%) and 64 (16%) had severe distress in somatic symptoms, anxiety/ insomnia, social dysfunction and severe depression, respectively.
ConclusionConsidering that more than half of the Iranian OB-GYN assistants had poor mental health, it seems that the COVID-19 pandemic has had a negative and destructive effect on the mental health of OB-GYN assistants. In this situation, they need psychological support and appropriate intervention.
-
-
-
Comparing Health Anxiety and Social Exclusion in the Elderlies and Adults Referring to the Veterans Foundation in COVID-19 Pandemic
Available online: 14 October 2024More LessObjectiveCovid-19 pandemic is a global challenge negatively affecting various aspects of health of different age groups. One of the groups involved with the psychological challenges of Covid-19 were the veterans and their families. So, this study was conducted to compare the health anxiety and social exclusion in elderlies and youths referring to the Veteran Foundation in Covid-19 pandemic.
MethodsThis descriptive study was conducted on 114 clients of the Veterans Foundation in order to compare the health anxiety and social exclusion in the elderlies and adults referring to Veterans Foundation in the Covid-19 pandemic. The participants were collected through convenience sampling. Data were collected using demographic, health anxiety and social exclusion questionnaires.
ResultsIn the comparison of social exclusion and its sub-dimensions, the variables of Out-group social support, participation and shame have a significant difference (P<0.05) and the average of out-group support in the adults is more than in the elderlies, while the average of participation and social shame is higher in the elderlies than the adults. There is an inverse and significant correlation between the indicators of social relations, participation and the total social exclusion with health anxiety in youths (P<0.05).
ConclusionGiven the risks of social exclusion on the physical and mental health of the elderlies and its correlation with health anxiety, it seems that, more attention should be paid to the effects of the disease on the mental and social health of the elderlies in Covid-19 prevention programs.
-
-
-
The Relationship of Self-Care Knowledge Towards COVID-19 Crisis with Anxiety and Quality of Life in Infertile Women
Available online: 11 October 2024More LessIntroductionSelf-care is any activity that establishes and maintains one’s own health and prevents and deals with illnesses. According to the evidence, epidemiological crises affect mental health. Also, dealing with infertility can lead to mental health issues. The present study aimed to investigate the relationship of self-care knowledge towards the COVID-19 crisis with anxiety and quality of life in infertile women.
MethodsA cross-sectional online survey via the social media platform WhatsApp based on convenience sampling of infertile women was conducted from April to December 2019 during the COVID-19 pandemic in Infertility centers of Shiraz (A metropolis in the South of Iran, center of Fars province). Data was collected by demographic and infertility-related data questionnaire, self-structured questionnaire of self-care knowledge towards the COVID-19 crisis, state anxiety questionnaires, and Spielberger's standardized quality of life using Porsline software by self-report. Inclusion criteria were infertile women active in the virtual network. SPSS software IBM company version 20 was used for data analysis.
ResultsMost of the participants (62.2%) had average self-care knowledge about Covid-19. There was an inverse, and significant relationship between self-care knowledge of COVID-19 and anxiety of infertile women, i. e., the lower level of self-care knowledge of infertile women towards Covid-19 crisis was associated with a higher level of anxiety (p < 0.05). No significant relationship was found between the level of self-care knowledge of COVID-19 and infertile women’s quality of life (P > 0.05).
ConclusionIncreasing self-care knowledge of COVID-19among infertile women could affect their mental health. Education and increasing self-care knowledge during pandemics are recommended to manage the anxiety of infertile women and, as a consequence, promote fertility.
-
-
-
Sunlight Resurgence in the COVID-19 Era: A Review on Health-risk Dualities via Ayurveda and Conventional Science Perspectives
Authors: Shalini Rai, Tanuja Nesari, Gayatri Rath, Anand More and Richa TripathiAvailable online: 11 October 2024More LessWith the advent of COVID-19, numerous scientific studies from different parts of the world emerged, documenting the beneficial effects of sunlight on decreasing transmittance, morbidity, and mortality due to COVID-19. Research also highlighted the beneficial effects of sunlight in terms of antimicrobial, antiviral effects, and vitamin D production and its role in improving immunity and decreasing mortality due to COVID-19. Along with this, also resurfaced the debate on the hype of the above-mentioned and other positive attributes and the negative attributes of sunlight in terms of causing skin cancer and aggravation of certain other disease conditions. This article revisits the scientific and historical evidence in the context of sunlight and presents an interdisciplinary, integrative perspective, including Ayurveda and conventional science, for the evaluation of the advantages and disadvantages and contemplation regarding the application of sunlight exposure in health care.
-
-
-
Nasal Vaccine: A Special Prominence on SARS-CoV-2
Available online: 09 October 2024More LessNasal administration of mucosal medications and vaccines is an alternate and promising method of drug and vaccine delivery. Mucosal pathways can be used selectively for various disorders due to many benefits. Many initiatives are now being made to yield effective medications and cutting-edge nasal delivery systems. The structure of the nasal cavity and key features were discussed in this review. With a focus on vaccine distribution, the benefits, successes, and difficulties of using the nasal route for medical purposes were examined. The strong result supports the benefits and security, of the safety of nasal medication and vaccination administration. This alternate path may help many unmet medical needs and may also make big vaccination drives or expensive, protracted chronic therapies possible. Today, despite some lingering criticism, the area of nasal medicine and vaccine delivery is expanding quickly, supported by recent advancements in nanotechnology, imaging, and administration devices. The variety of drugs that have been licensed for nasal delivery is expected to increase significantly.
-
-
-
Systematic Analysis of the Zoonosis by SARS-CoV-2 in Domestic Cats Under the Concept of One Health
Available online: 09 October 2024More LessObjectiveThis study aimed to identify scientific evidence on the zoonotic transmission of SARS-CoV-2 in domestic felines in order to observe the relationship between the susceptibility of cats to SARS-CoV-2, the infection of humans to cats regarding the virus, and the relationship between cat-to-human transmission of SARS-CoV-2.
MethodsA systematic review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) method. Four scientific databases (Google Scholar, PubMed, Scielo, and Web of Science) were used for article search, and the review was limited until July 1, 2023.
ResultsA total of 2327 articles were identified from the three databases, of which 16 were finally included in the review. Eight articles provided information on the high susceptibility of cats to SARS-CoV-2, 7 articles described the characteristics of clinical signs presented in both humans and cats, and only 1 article discussed the infection from a cat to a human.
ConclusionIt is important to consider isolating pets during the latency period of the disease within medical recommendations, reinforce the use of eye protection, and adopt the concept of “One Health” to prevent public health problems.
-
-
-
Exploring the Efficacy of Convalescent Plasma Therapy in COVID-19 Patients: A Clinical Trial Study
Available online: 09 October 2024More LessBackgroundIn December 2019, a group of patients in Wuhan, Hubei province, China, presented with severe illness and pneumonia of unknown origin. Subsequently, a novel coronavirus was identified as the cause and named “2019 novel coronavirus” (2019-nCoV), later defined as “SARS-CoV-2” (Severe Acute Respiratory Syndrome Coronavirus-2), leading to the development of the disease known as COVID-19. This study aimed to evaluate the effectiveness and safety of convalescent plasma as a potential therapy for patients with COVID-19.
MethodsPatients diagnosed with COVID-19 based on real-time polymerase chain reaction (PCR) or CT-Scan symptoms were randomly assigned to either the treatment group (n = 29, received convalescent plasma) or the control group (n = 29). Clinical manifestations and pulmonary involvement were monitored three times during the study. At the end of the intervention, patients were evaluated for clinical symptoms, laboratory test results, and length of hospital stay.
ResultsAmong the 58 patients who completed the study, there were no significant differences in baseline characteristics between the treatment and control groups upon admission to the hospital. However, the length of hospital stay was significantly shorter (9.54 days) in the convalescent plasma group compared to the control group (12.88 days).
ConclusionThe findings from this study indicate that the use of convalescent plasma therapy, in addition to standard treatment, did not result in reduced mortality or improved clinical outcomes at day 7 when compared to a placebo or control group.
-
-
-
Investigating the Relationship between the Health Literacy of COVID-19 Patients and the Burden of Family Caregivers
Authors: Rasoul Raesi, Leila Sadeghmoghadam, Ali Mohammadpour, Samane Najafi and Yones MovahediAvailable online: 09 October 2024More LessBackgroundThe COVID-19 pandemic was associated with the challenge of health literacy of patients and the care burden of family caregivers.
AimThe present study was conducted to determine the relationship between the health literacy of patients discharged with the diagnosis of COVID-19 and the care burden of family caregivers.
MethodsThis descriptive and analytical study was conducted on 290 people who were COVID-19 patients and 290 people who were their family caregivers in 2022. The study used the convenience sampling method in hospitals located in 22 Bahman Khaf and Allameh Bohlol Gonabadi. The data were collected using the health literacy questionnaire of Montazeri et al. (2005) and the burden of care questionnaire of Zarit et al. (1998). The data were analyzed using SPSS-22 statistical software and Kolmogorov-Smirnov, independent t, Pearson correlation coefficient, and ANOVA tests at a significance level of 0.05.
ResultsThe level of health literacy in most patients was weak. The burden of care for most family caregivers was severe. There was a negative and significant relationship between the health literacy of patients in general and the care burden of family caregivers in general (p<0.001). For an increase of one health literacy score in general, the care burden score decreases by 0.44.
ConclusionAs the health literacy of patients increases, the care burden of their family caregivers decreases. Therefore, scientific and practical training plans for patients are recommended to health policymakers to improve health literacy and ultimately reduce the care burden of family caregivers.
-
-
-
Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19-PIMS-grade 3: A Case Report
Available online: 08 October 2024More LessBackgroundIn the face of the rise of COVID-19, the multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19 has been reported, and an increase in MIS-C cases has been observed throughout the world. The majority of these cases were similar to Kawasaki disease concerning clinical presentation.
Case PresentationDespite similarities, MIS-C cases present clinical and laboratory differentiation, which makes it essential to portray similar cases worldwide to have a better consensus in the future. A 7-year-old male child visited the hospital with the chief complaints of fever associated with chills, rigors, and excessive myalgia for 3 days. He had a history of elevated high C-reactive protein (CRP) of 42.7 mg/L. He was diagnosed with Paediatric inflammatory multisystem syndrome (PIMS)-grade 3. Here, for the first time, we bring an Indian MIS-C case with COVID-19-associated Paediatric inflammatory multisystem syndrome (PIMS)-grade 3.
ConclusionPIMS-TS infection in paediatrics is associated with a wider range of complications, and the importance of musculoskeletal complications in PIMS-TS has been discussed.
-
-
-
Antimicrobial Susceptibility Profile of Bacteria Isolated from Hemocultures of Patients Attended in a Campaign Hospital During COVID-19 Pandemic
Available online: 04 October 2024More LessIntroductionPrimary bloodstream infections are most commonly related to health care and are associated with intravascular devices, increasing patient mortality, length of stay, and health care costs. Among the complications of hospitalizations for COVID-19, bloodstream infection is one of the most prevalent, requiring prevention and early treatment. Due to the contingency of hospital resources during the pandemic, understanding the prevalence and incidence of antimicrobial agents that cause bloodstream infections and using exams judiciously are essential public health measures, avoiding the misuse of antimicrobials and being able to establish treatment.
ObjectiveThis study aimed to determine the antimicrobial susceptibility profile and the prevalence of etiological agents of bloodstream infections in patients with COVID-19 at the field hospital in the city of São Bernardo do Campo - SP.
MethodA descriptive, observational, and retrospective cross-sectional study was carried out on the results of blood cultures already collected for diagnostic purposes from patients from May to August 2020 at the same hospital.
ResultsOf the 300 blood cultures analyzed, 73.7% of the samples showed no bacterial growth. Among the others, the main bacteria found were Klebsiella pneumoniae, sensitive to tigecycline, present in 30 (10%), followed by Staphylococcus sp. (coagulase-negative, non-lugdunensis), sensitive only to doxycycline, gentamicin, tetracycline, and vancomycin, in only 2 (14.3%) samples.
ConclusionIn this study, a low rate of laboratory-confirmed bacterial coinfection was identified in patients with COVID-19.
-
-
-
Cleaning and Disinfection of Surfaces in a COVID-19 Respiratory Syndrome Unit: A Quasi-Experimental Study
Available online: 04 October 2024More LessObjectiveThis study aimed to assess the impact of an educational intervention on the cleaning and disinfection processes within a respiratory syndrome unit, serving as a designated facility for COVID-19 patients.
MethodsA quasi-experimental design was employed, incorporating a pre-intervention and post-intervention assessment. The evaluation of surfaces involved various monitoring techniques, including Adenosine Triphosphate (ATP) testing, colony-forming unit analysis, and visual inspections. All statistical analyses were conducted at a significance level of 5% (p < 0.05).
ResultsFollowing the implementation of the educational intervention, a notable reduction in surface contamination rates was observed. Significant improvements were noted for specific surfaces when utilizing the ATP testing method, including benchtops (p = 0.030), mattresses (p = 0.014), doorknobs (p = 0.014), and armchairs (p = 0.014). Furthermore, a decrease in the total count of aerobic bacteria was observed for benchtops (p = 0.014), mattresses (p = 0.014), and doorknobs (p = 0.014). Visual inspection results also indicated enhancements, with approval rates for benchtops, armchairs, and mattresses rising from 0% before the intervention to 37.5% afterward.
ConclusionThe findings of this study demonstrate substantial improvements in approval rates following the implementation of the educational intervention. Additionally, this research provides valuable insights for the development of ongoing educational initiatives for the healthcare team, incorporating evaluation and feedback mechanisms as well as updates to cleaning and disinfection protocols.
-
-
-
Correct Use of HCQ Did Not Cause Extra Fatalities in COVID-19 Infection
Authors: Alberto Boretti and Bimal BanikAvailable online: 16 September 2024More LessA recent study has claimed that nearly 17,000 people in the U.S. and five other countries died prematurely during the early stages of the COVID-19 pandemic due to the compassionate use of hydroxychloroquine (HCQ) for treatment. However, this study's conclusions are contentious due to reliance on flawed data and the neglect of significant evidence supporting HCQ's efficacy in early outpatient treatment. Our critique challenges the validity of the study, highlighting its methodological weaknesses and the confounding factors it overlooked. By reviewing the comprehensive body of scientific literature, we demonstrate that treatment with HCQ, particularly in combination with zinc and antibiotics, consistently yielded positive outcomes, especially in the early stages. This work aims to provide a balanced and objective assessment of HCQ's impact on COVID-19, emphasizing the importance of early intervention and proper dosage.
-
-
-
Updated COVID‐19 Pharmacotherapy in Different Diseases Such as Cancer
Available online: 06 May 2024More LessBackgroundStudies suggest that cancer is a main complication regarding life expectancy and a foremost reason for death worldwide. For the treatment of COVID-19 infected 703,525,337 cases with 6,984,801 deaths worldwide up to February 21, 2024, well-designed pharmacotherapy management in different diseases, such as cancer, is respected. This investigation aims to review the current accessible medical treatment for patients with different diseases, cancer, and COVID-19.
MethodsThe appropriate documents for this review were achieved by searching databases such as Web of Science, Scopus, and PUBMED. Relevant studies included in review articles, clinical trials, and case reports that were evaluated and used (n=109 articles).
ResultsIn those with cancer and COVID-19, publications reported worsened clinical conditions with a considerably higher risk of death. The result of existing regular antitumor management could be a basis of debate. In the general population, asymptomatic patients with positive nasopharyngeal swabs are recommended to receive antibiotic prophylaxis, and in those with symptomatic signs, adjustment of angiotensin-converting enzyme based on anti-hypertensive therapy should be considered. In patients with liver disease, nitazoxanide plus sofosbuvir, ivermectin, tocilizumab, convalescent plasma, and low molecular weight heparin in certain situations is recommended. Furthermore, favipiravir, chloroquine, and hydroxychloroquine could also be recommended, but with caution regarding to polypharmacy interactions. For those with moderate disease, hydroxychloroquine or chloroquine/azithromycin was recommended. In the patients with respiratory failure, convalescent plasma was suggested. In the populations where those symptoms progress to the sign of a cytokine storm, the antagonists of interleukin-6 (IL-6) were suggested. To reduce fever, however, ibuprofen showed more potent efficacy compared to acetaminophen, but it may delay the benefits of a fever response.
ConclusionOwing to the immune suppression that could be caused by anti-cancer drugs and deterioration of lung functions due to COVID-19, for proposed management regarding pharmacotherapy strategies, further evidence-based studies seem to be advantageous.
-